Focusfreda's "Lysine Hyaluronate" Obtains New Cosmetic Ingredient Approval
On February 5, the National Medical Products Administration (NMPA) announced that Focusfreda's innovative' lysine hyaluronate 'had successfully obtained registration as a new cosmetic ingredient (Registration No.: Guozhuangyuanbei Zi 20260026). This marks the company's first registration of a new cosmetic ingredient, representing a significant achievement in its active response to Freda's' Hyaluronic Acid+ 'industrial structure optimization strategy. The milestone signifies Focusfreda's crucial step into the field of cosmetic new ingredients, officially positioning the company at the forefront of innovative research and development of active cosmetic components.
Lysine hyaluronate is a hyaluronic acid-functionalized derivative formed by the combination of hyaluronic acid and the natural amino acid lysine. This raw material retains the excellent moisturizing, film-forming, and lubricating properties of hyaluronic acid while significantly enhancing the affinity and binding stability of the modified molecule with the skin's stratum corneum proteins and aqueous environment due to the lysine modification. Additionally, this modified structure endows the raw material with superior anti-enzymatic degradation characteristics and formulation adaptability, demonstrating good biocompatibility.
This raw material is primarily used in products such as serums, emulsions/creams, masks, sprays, eye care, and pre-makeup/base makeup. Its formula demonstrates strong compatibility, not only exhibiting excellent stabilizing and reparative effects when used alone, but also synergistically enhancing with classic antioxidant and moisturizing ingredients like ergotin and panthenol. This combination significantly improves the overall efficacy of the formulation, providing the skin with a more comprehensive and efficient defense and repair solution.
The successful completion of this filing marks a milestone achievement in the collaborative R&D and joint efforts between Focusfreda and the Shandong Academy of Pharmaceutical Sciences. This outcome fully demonstrates the company's long-term expertise and rigorous standards in ensuring the safety, efficacy, and quality controllability of raw materials. Meanwhile, this progress also provides a practical reference and exemplary significance for the industrial application of hyaluronic acid derivatives in China.
Looking ahead, Focusfreda will continue to deepen its research and development in hyaluronic acid functional modification technology, focusing on high activity, high stability, and high adaptability. The company aims to develop more hyaluronic acid derivatives with differentiated competitiveness, accelerating the localization and high-end upgrading of domestic cosmetic raw materials. This initiative will provide the industry with safer, more efficient, and more application-value-oriented active ingredient solutions.
CONTACT US
Tel：+86-0537-3195566
E-mail：sales@focuschem.com
Add：Economic Development Zone, High-speed Railway New District, Qufu City, Jining City, Shandong Province, China
Copyright © 2022 Shandong Focusfreda Biotech Co., Ltd. 鲁ICP备2021008509号-2 Powerby : 300.cn jinan SEO